The latest closing stock price for Kyverna Therapeutics as of October 04, 2024 is 4.63.
An investor who bought $1,000 worth of Kyverna Therapeutics stock at the IPO in 2024 would have $-846 today, roughly -1 times their original investment - a -84.57% compound annual growth rate over 1 years.
The all-time high Kyverna Therapeutics stock closing price was 30.10 on February 09, 2024.
The Kyverna Therapeutics 52-week high stock price is 35.06, which is 657.2% above the current share price.
The Kyverna Therapeutics 52-week low stock price is 4.51, which is 2.6% below the current share price.
The average Kyverna Therapeutics stock price for the last 52 weeks is 14.77.
An investor who bought $1,000 worth of Kyverna Therapeutics stock at the IPO in 2024 would have $-846 today, roughly -1 times their original investment - a -84.57% compound annual growth rate over 1 years.
The all-time high Kyverna Therapeutics stock closing price was 30.10 on February 09, 2024.
The Kyverna Therapeutics 52-week high stock price is 35.06, which is 657.2% above the current share price.
The Kyverna Therapeutics 52-week low stock price is 4.51, which is 2.6% below the current share price.
The average Kyverna Therapeutics stock price for the last 52 weeks is 14.77.